Hypothalamic PKC regulates Glucose Production

  1. Rachel Ross1,
  2. Penny Y.T. Wang2,
  3. Madhu Chari2,,3,
  4. Carol K.L. Lam2,,3,
  5. Liora Caspi2,
  6. Hiraku Ono1,
  7. Evan D Muse1,
  8. Xiaosong Li1,
  9. Roger Gutierrez-Juarez1,
  10. Peter E Light4,
  11. Gary J Schwartz1,
  12. Luciano Rossetti1 and
  13. Tony K.T. Lam (tony.lam{at}uhnres.utoronto.ca)2,,3
  1. 1Departments of Molecular Pharmacology, Medicine and Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA
  2. 2Toronto General Hospital Research Institute, University Health Network, Toronto, M5G 1L7, Canada
  3. 3Departments of Physiology and Medicine, University of Toronto, Toronto, M5S 1A8, Canada
  4. 4Department of Pharmacology, University of Alberta, Edmonton, T6G 2H7, Canada

    Abstract

    Objective: A selective rise in hypothalamic lipid metabolism and the subsequent activation of SUR1/Kir6.2 ATP-sensitive potassium (KATP) channels inhibit hepatic glucose production (GP). The mechanisms that link the ability of hypothalamic lipid metabolism to the activation of KATP channels remain unknown.

    Research Design And Methods: To examine whether hypothalamic protein kinase C (PKC) mediates the ability of CNS lipids to activate KATP channels and regulate GP in normal rodents, we first activated hypothalamic PKC in the absence or presence of KATP channel inhibition. We then inhibited hypothalamic PKC in the presence of lipids. Tracer-dilution methodology in combination with the pancreatic clamp technique was used to assess the effect of hypothalamic administrations on glucose metabolism in vivo.

    Results: We first reported that direct activation of hypothalamic PKC via direct hypothalamic delivery of PKC activator 1-Oleoyl-2-acetyl-sn-glycerol (OAG) suppressed GP. Co-administration of hypothalamic PKC-δ inhibitor rottlerin with OAG prevented the ability of OAG to activate PKC-δ and lower GP. Furthermore, hypothalamic dominant negative-Kir6.2 expression or the delivery of the KATP channel blocker glibenclamide abolished the GP lowering effects of OAG. Finally, inhibition of hypothalamic PKC eliminated the ability of lipids to lower GP.

    Conclusion: These studies indicate that hypothalamic PKC activation is sufficient and necessary to lower GP.

    Footnotes

      • Received February 13, 2008.
      • Accepted May 16, 2008.